Concepedia

Megan McNamara

MM

Statistics

Publications

14

Citations

444

H-Index

14

Active since

1997

Affiliations

Duke University(Current)

Duke Medical Center

Duke Cancer Institute

The Barbara Ann Karmanos Cancer Institute

University of North Carolina at Chapel Hill

Megan McNamara is an author at Duke University specializing in oncology, medicine, and prostate cancer.

Publications per year

1997–2024

14

Publications

14

Recombinant oncolytic poliovirus, PVSRIPO, has potent cytotoxic and innate inflammatory effects, mediating therapy in human breast and prostate cancer xenograft models

Eda K. Holl, Michael C. Brown, David Boczkowski et al. · Oncotarget · 2016 · 70 citations · Full text

Life Sciences, Immunology, Oncology +14

Expression of immune checkpoints on circulating tumor cells in men with metastatic prostate cancer

Tian Zhang, Anika Agarwal, R. Garland Almquist et al. · Biomarker Research · 2021 · 49 citations · Full text

Life Sciences, Immunology, Oncology +17

Acute corticosterone replacement reinstates performance on spatial and nonspatial memory tasks 3 months after adrenalectomy despite degeneration in the dentate gyrus.

Cheryl M. McCormick, Megan McNamara, Shiuli Mukhopadhyay et al. · Behavioral Neuroscience · 1997 · 44 citations

Social Sciences, Neurobiology, Neuroscience +17

A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate‐resistant prostate cancer

Daniel J. George, Susan Halabi, Elisabeth I. Heath et al. · Cancer · 2021 · 39 citations · Full text

Medicine, Oncology, Urology +17

Abi Race: A prospective, multicenter study of black (B) and white (W) patients (pts) with metastatic castrate resistant prostate cancer (mCRPC) treated with abiraterone acetate and prednisone (AAP).

Daniel J. George, Elisabeth I. Heath, Oliver Sartor et al. · Journal of Clinical Oncology · 2018 · 36 citations

Medicine, Oncology, Pharmacology +16

1–5 of 14